glp 1 agonist therapy New GLP-1 Guidelines for Type 2 Diabetes in 2025 Potential Use of GLP-1 and
Description
Erem C, Hacihasanolu A, Celik S, Ovali E, Ersz HO, Ukin K, et al
For individuals prescribed GLP-1 receptor agonists as part of a comprehensive diabetes or obesity management plan, incorporating allulose as a sugar substitute could support treatment goals without compromising palatability
doi:10.1152/ajpendo.1997.273.5.E981 22
[DOI] [PubMed] [Google Scholar] 602.Inoue K., Hiramatsu S., Hisatomi A., Umeda F., Nawata H
166 , 199207.e115 (2013)
